TREATMENT
Clinical trials for TREATMENT explained in plain language.
Never miss a new study
Get alerted when new TREATMENT trials appear
Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis study tests whether adding an anti-CD38 antibody to the standard drug rituximab works better than rituximab alone for adults with immune thrombocytopenia (ITP) who did not improve or relapsed after steroid treatment. The goal is to raise platelet counts and reduce bleeding r…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
New drug combo aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis study tests whether combining two drugs—rituximab and daratumumab—can safely raise platelet counts in adults with immune thrombocytopenia (ITP) who no longer respond to steroids. About 20 participants will receive the combination and be monitored for 12 weeks. The goal is to…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC